Chin J Cancer. 2010 Oct;29(10):855-9.
Esophageal carcinoma is one of the most common human cancers in China. Radiotherapy plays an important role in combination therapy of esophageal carcinoma. With regret, there is still no unified standard for the treatment of esophageal carcinoma in China, and there are many controversies in the treatment regimens, indications, methods and efficacy. Clinically, the clinical practice guidelines of the National Comprehensive Cancer Network (NCCN) of the United States were often consulted, but the data of them were mainly from the patients from Europe and America, and they might not be applicable for Chinese patients. In order to standardize clinical process of radiotherapy for esophageal carcinoma in China, the Esophageal Carcinoma Cooperative Group of Radiation Oncology Society of Chinese Medical Association wrote a consensus and controversies on the radiotherapy for esophageal carcinoma (draft) after years of research and discussion. We hope it be tried out and discussed with advice and valuable suggestions, in order to accelerate the process of standardization of esophageal carcinoma treatment in China.
食管癌是中国最常见的人类癌症之一。放射治疗在食管癌的综合治疗中发挥着重要作用。遗憾的是，中国食管癌的治疗仍没有统一标准，在治疗方案、适应证、方法及疗效等方面存在诸多争议。临床上，常参考美国国立综合癌症网络（NCCN）的临床实践指南，但其中的数据主要来自欧美患者，可能不适用于中国患者。为规范中国食管癌放射治疗的临床流程，中华医学会放射肿瘤学分会食管癌协作组经过多年研究和讨论，撰写了食管癌放射治疗的共识与争议（草案）。我们希望将其试行并广泛征求意见和宝贵建议，以加快中国食管癌治疗的规范化进程。
